Related Experiment Video
Updated: Jun 13, 2026

Improved Home Blood Pressure Control by CT-guided Ozone-mediated Renal Denervation for Patients with Resistant Hypertension
Published on: June 6, 2025
Achieving blood pressure control in clinical practice
1Department of Cardiovascular Sciences, University of Leicester, Leicester, United Kingdom.
Insights
Lowering blood pressure (BP) offers significant cardiovascular benefits, even with small improvements. Early intervention with combination therapy may overcome resistance and prevent long-term complications.
Area of Science:
- Cardiology
- Pharmacology
- Hypertension Management
Background:
- Antihypertensive treatments primarily benefit patients through blood pressure (BP) reduction.
- Even minor BP improvements can significantly impact cardiovascular disease progression and atherosclerosis.
- Achieving adequate BP control is challenging in clinical practice, often leading to treatment-resistant cases.
Purpose of the Study:
- To explore the potential benefits of earlier intervention in managing hypertension.
- To investigate the efficacy of initial combination therapy in overcoming BP counter-regulatory mechanisms.
- To reduce long-term reliance on multiple medications for hypertension.
Main Methods:
- The study reviews existing clinical trial data on antihypertensive treatments.
- It analyzes the impact of BP-lowering on cardiovascular disease and atherosclerosis.
- The role of the renin-angiotensin system in treatment response is examined.
Main Results:
- Blood pressure lowering is the primary driver of benefits in antihypertensive therapy.
- Early intervention and combination therapy may prevent disease progression and treatment resistance.
- Addressing counter-regulatory mechanisms can improve treatment efficacy.
Conclusions:
- Earlier antihypertensive intervention, potentially with initial combination therapy, is advisable.
- This approach may overcome renin-angiotensin system-mediated resistance and improve patient outcomes.
- Combination therapy can lead to more predictable BP responses and reduce treatment complexity.
Abstract:
There are an overwhelming number of clinical trials that show that the main benefits of antihypertensive treatment are associated with blood pressure (BP)-lowering. Even small improvements in BP, or moving from a "prehypertensive" to a "normal" BP state, can have a dramatic effect on the progression of early-stage cardiovascular disease, and may actually regress the development of atherosclerosis. However, achieving adequate BP control can be very difficult, even under the scrutiny of a clinical trial setting; in general practice it is even harder. If physicians wait to the point at which arterial damage is well established, then we will always be striving to treat difficult or treatment-resistant patients. The difficulty in achieving BP-lowering is further aggravated by the involvement of a renin-angiotensin system-mediated counter-regulatory mechanism that offsets vasodilatory drugs and blunts dose response. Such issues raise the question of whether physicians should contemplate earlier intervention or initial combination therapy in order to prevent the evolution of damage, overcome the counter-regulatory mechanism, and minimize the need for multiple drug use in the long-term. Using combination therapy at an earlier stage would also remove heterogeneity in BP response and may reduce treatment resistance.
Related Concept Videos
Errors occurring during blood pressure monitoring
Several factors...
Hypertension IV: Drug Therapy and Lifestyle Modifications
Blood Pressure
The average BP in an adult is typically around 120/80 mmHg (millimeters of mercury). In this measurement, the numerator (120) indicates the systolic pressure, which is the pressure in the arteries during the contraction of the heart's ventricles as blood is expelled. The denominator (80) represents the diastolic...
Blood Pressure
Factors affecting Blood pressure
Physiological Factors:
Hypertension V: Nursing Management